Drug Markets/Oxymetazoline Hydrochloride

Oxymetazoline Hydrochloride

30 NDCs across 13 manufacturers|20 Generic,10 Brand

Oxymetazoline Hydrochloride is used to treat common cold, conjunctivitis, rhinitis and sinusitis, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on May 30, 1986, and the first generic was approved Oct 4, 2021. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient.

Oxymetazoline Hydrochloride is available as 30 NDCs from 13 manufacturers (20 generic, 10 brand), with NADAC prices from $0.06 to $0.36 per MLthe most expensive product costs about 5.8× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

30

20G / 10B

Manufacturers

13

competing in market

Price Spread

$0.06 – $0.36

per ML, 28 of 30 NDCs

7d Activity

9516 flat

avg -0.7% WoW · of 30 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

30 NDCs total, 30 shown

Drug Price 7d Change
RHOFADE 1% CREAM
$23.4789
per GM
+0.06%
RHOFADE 1% CREAM
$22.5013
per GM
MUCINEX SINUS-MAX NASAL SPRAY
$0.3610
per ML
MUCINEX SINUS-MAX NASAL SPRAY
$0.3610
per ML
AFRIN NO DRIP PUMP MIST
$0.3443
per ML
AFRIN NO DRIP ORIG PUMP MIST
$0.3443
per ML
AFRIN 0.05% NASAL SPRAY
$0.3089
per ML
AFRIN 0.05% NASAL SPRAY
$0.3089
per ML
AFRIN 0.05% NASAL SPRAY
$0.3089
per ML
AFRIN 0.05% NASAL SPRAY
$0.2247
per ML
QC NO DRIP NASAL MIST 0.05%
$0.1370
per ML
NASAL DECONGESTANT 0.05% SPRAY
$0.1218
per ML
+1.36%
QC NO DRIP NASAL MIST 0.05%
$0.1049
per ML
-4.58%
QC NO DRIP NASAL MIST 0.05%
$0.1049
per ML
-4.58%
FT NASAL SPRAY 0.05%
$0.1049
per ML
-4.58%
NASAL DECONGESTANT 0.05% SPRAY
$0.1049
per ML
-4.58%
GNP NO DRIP NASAL MIST 0.05%
$0.1049
per ML
-4.58%
SM NASAL SPRAY 0.05%
$0.0763
per ML
FT NASAL SPRAY 0.05%
$0.0757
per ML
+1.61%
QC NASAL SPRAY 0.05%
$0.0757
per ML
+1.61%
FT NASAL SPRAY 0.05%
$0.0757
per ML
+1.61%
NASAL SPRAY ORIGINAL 0.05%
$0.0757
per ML
+1.61%
NASAL SPRAY 0.05%
$0.0757
per ML
+1.61%
NASAL DECONGESTANT 0.05% SPRAY
$0.0757
per ML
+1.61%
GS NASAL SPRAY 0.05%
$0.0757
per ML
+1.61%
GS SINUS NASAL SPRAY 0.05%
$0.0737
per ML
NASAL DECONGESTANT 0.05% SPRAY
$0.0678
per ML
NASAL DECONGESTANT 0.05% SPRAY
$0.0625
per ML
NASAL SPRAY 0.05%
$0.0625
per ML
NASAL SPRAY 0.05%
$0.0625
per ML

Frequently Asked Questions

What is Oxymetazoline Hydrochloride used to treat?

Oxymetazoline Hydrochloride is used to treat common cold, conjunctivitis, rhinitis and sinusitis, per the National Library of Medicine's MED-RT classification.

When did Oxymetazoline Hydrochloride become available as a generic?

FDA approved the first generic Oxymetazoline Hydrochloride (ANDA) on Oct 4, 2021. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How many Oxymetazoline Hydrochloride products are on the market?

The Oxymetazoline Hydrochloride drug market contains 30 NDCs from 13 manufacturers — 20 generic and 10 brand products.

What is the price range for Oxymetazoline Hydrochloride?

NADAC reference prices for Oxymetazoline Hydrochloride range from $0.0625 to $0.3610 per ML — the most expensive product costs about 5.8× the cheapest. 2 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.

Is generic Oxymetazoline Hydrochloride cheaper than brand?

The average generic NADAC for Oxymetazoline Hydrochloride is $0.0859 per ML, versus $0.3202 for brand-labeled products — brand versions average about 3.7× the generic price.

Which manufacturers make Oxymetazoline Hydrochloride?

13 manufacturers list Oxymetazoline Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Bayer HealthCare LLC (6), Chain Drug Marketing Association (4), Strategic Sourcing Services LLC (4), RB Health (US) LLC (2), Major Pharmaceuticals (2).

How has the price of Oxymetazoline Hydrochloride changed recently?

Over the past 7 days, 9 Oxymetazoline Hydrochloride NDCs rose and 5 fell, with a market-wide average change of -0.7%.